AGOPTON

Brand name authorized in: Austria Germany

Active ingredients

The drug AGOPTON contains one active pharmaceutical ingredient (API):

1 Lansoprazole
UNII 0K5C5T2QPG - LANSOPRAZOLE

Lansoprazole is a gastric proton pump inhibitor. It inhibits the final stage of gastric acid formation by inhibiting the activity of H+/K+ ATPase of the parietal cells in the stomach. The inhibition is dose-dependent and reversible, and the effect applies to both basal and stimulated secretion of gastric acid.

Read about Lansoprazole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Lansoprazole
A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC03

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
DE
Bundesinstitut für Arzneimittel und Medizinprodukte
Identifier(s): 06794515, 06794550